Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Fierce Pharma
Mon, 02/26/18 - 11:30 am
drug launches
hepatitis C
Ibrance
Tecfidera
Biogen
Pfizer
Gilead Sciences
Biogen’s key Alzheimer’s disease drug is facing potential signs of trouble
Marketwatch
Sun, 02/18/18 - 10:12 am
Biogen
Alzheimer's disease
aducanumab
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
AbbVie
Allergan
Roche
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Biogen tweaks Alzheimer’s phase 3, sparking stock slide
Fierce Biotech
Thu, 02/15/18 - 09:39 am
Biogen
Alzheimer's disease
clinical trials
aducanumab
Top 10 most productive workforces in biopharma
Fierce Pharma
Mon, 02/12/18 - 11:03 am
Pharma
pharma employees
productivity
Gilead Sciences
Celgene
Pfizer
AbbVie
Biogen
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Xtalks
Thu, 02/8/18 - 10:11 am
Biogen
stroke
clinical trials
natalizumab
Biogen scuttles a Tysabri program after the drug fails stroke test, thinning the pipeline
Endpoints
Wed, 02/7/18 - 10:03 am
Biogen
Tysabri
ischemic stroke
Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab
Motley Fool
Mon, 01/29/18 - 11:56 pm
Biogen
aducanumab
earnings
Why big pharma companies always create new spinoffs
GoinPharma
Sun, 01/28/18 - 10:06 am
spinoffs
Sanofi
Celgene
Biogen
AbbVie
Abbott Labs
Baxalta
Shire
Biogen's in the hunt for late-stage assets, executives say amid Q4 revenue beat
Fierce Pharma
Fri, 01/26/18 - 09:35 am
Biogen
earnings
M&A
Biogen: Where Is That Blockbuster Acquisition?
Forbes
Thu, 01/25/18 - 05:54 pm
Biogen
M&A
Earnings Preview: What To Expect From Biogen On Thursday
Forbes
Tue, 01/23/18 - 08:45 am
earnings
Biogen
Sanofi to Buy Biogen Hemophilia Spinoff for $11.6 Billion
Bloomberg
Mon, 01/22/18 - 11:05 am
Sanofi
M&A
Bioverativ
Biogen
hemophilia
Whom Will Pfizer Buy in 2018?
Motley Fool
Mon, 01/22/18 - 09:42 am
Pfizer
M&A
Biogen
Bristol-Myers Squibb
Allergan
Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report
Endpoints
Fri, 01/19/18 - 11:15 am
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Closing JPM18: Winners and losers, brighter days for neuroscience
Biopharma Dive
Sat, 01/13/18 - 10:58 pm
JPMHC 2018
Neurosciences
China
Sanofi
tax reform
GSK
Biogen
Celgene
channel stuffing
Biogen Unlikely To See Spinraza Rival In 2018 As AveXis Delayed
Investors Business Daily
Fri, 01/5/18 - 05:44 pm
Biogen
Spinraza
AveXis
AVXS-101
spinal muscular atrophy
Biogen set to raise $300M from New Year's price hikes, just enough to offset MS competition
Fierce Pharma
Thu, 01/4/18 - 12:14 am
Biogen
MS
multiple sclerosis
drug pricing
Looking for an early success in PhII Alzheimer’s study, Biogen and Eisai just racked up the latest setback
Endpoints
Thu, 12/21/17 - 10:26 am
Biogen
Eisai
clinical trials
Alzheimer's disease
BAN2401
Biogen, Ionis looking for new SMA drugs following Spinraza's success
BioPharma Dive
Wed, 12/20/17 - 11:05 pm
Biogen
Ionis Pharmaceuticals
SMA
Spinraza
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »